The Department of Health and Human Services Friday announced the new option of saliva tests at federal community-based testing sites in areas experiencing COVID-19 surge.

The tests, in which patients spit into sterile containers, are made by Fludigm Corp. with support from the National Institutes of Health. Waco, Texas, is the first surge testing site to offer the saliva tests. HHS said the test’s accuracy is comparable to other molecular-level tests of nasal swab samples, based on the manufacturer’s clinical study.

Related News Articles

Blog
The RAND Corporation recently released the fifth iteration of its biannual hospital price report. The AHA has previously highlighted significant flaws with…
Headline
Adults age 65 and older are encouraged to receive an updated dosage of the COVID-19 vaccine, the Centers for Disease Control and Prevention announced April 25…
Headline
The Pfizer and Moderna COVID-19 vaccines can cause myocarditis, but do not appear to cause infertility, Guillain-Barré syndrome, Bell’s palsy, thrombosis with…
Headline
The Food and Drug Administration recently granted emergency use authorization for the first over-the-counter home antigen test to detect both flu and COVID-19…
Headline
Centers for Disease Control and Prevention Director Mandy Cohen, M.D., Feb. 28 endorsed a recommendation by its Advisory Committee on Immunization Practices…
Headline
Paxlovid may no longer be distributed with an emergency use label after March 8, the Food and Drug Administration announced. Providers may dispense unexpired…